Is Zantac safe?

April 3, 2020 | By Riddle & Brantley Accident Injury Lawyers
Is Zantac safe?

Many are wondering “Is Zantac safe?” Here’s what we know and don’t know about the rapidly unfolding situation concerning the potential that Zantac causes cancer. Is Zantac Safe? What You Need to Know About Potential Cancer Risk The FDA recently ordered Zantac and generic ranitidine manufacturers to stop selling these popular heartburn medications due to potential cancer risk from NDMA contamination. Is Zantac SafeTo be clear, there have been no tests establishing a direct causal relationship between Zantac and cancer, however the evidence is disturbing at best. Both independent labs and the FDA have determined that Zantac and other ranitidine-containing medications are contaminated with NDMA — a chemical that has been determined to cause cancer in humans. In a statement describing NDMA contamination, the FDA said that levels of NDMA were “unacceptable.” David Light, CEO for Valisure, the lab that first discovered NDMA contamination in ranitidine, was blunt: “There is no acceptable cancer risk for a drug like this.” So, while conclusive tests have not established a direct causal link, here’s what we know about whether or not Zantac is safe:

  • The FDA warns that Zantac is contaminated with NDMA
  • NDMA is a known carcinogen, meaning it can cause cancer
So, is Zantac safe? At this point, the FDA has warned that Zantac is not safe to take and may potentially cause cancer. We can safely say that NDMA contamination has been discovered in Zantac, and NDMA is classified as a “probable carcinogen,” meaning a chemical that can cause cancer. What should those taking Zantac do now? In a statement accompanying its order that manufacturers stop selling Zantac and generic ranitidine, the FDA advised patients taking prescription Zantac to talk with their prescribing doctor immediately. Those taking over-the-counter Zantac or other ranitidine tablets are advised to immediately stop taking the drug and seek potential Zantac alternatives.

Have you taken Zantac and been diagnosed with cancer?

If you’ve been diagnosed with cancer after taking brand-name Zantac, you may be entitled to compensation. The FDA has determined that Zantac and generic ranitidine are contaminated with NDMA and may cause cancer. For a FREE consultation with a Zantac lawsuit attorney, please call 1-800-525-7111 or complete the short form below. Zantac Cancer Lawsuits - Riddle & BrantleyThe consultation is, there is no obligation, and you won’t pay any attorney fees unless we win your case and recover financial compensation for you. Please call 1-800-525-7111 today and let’s review your case. IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents. If you’ve been diagnosed with cancer potentially as a result of taking Zantac, you deserve justice — and you may be entitled to compensation. Potential cancers that may qualify you include:
  • Kidney cancer
  • Stomach cancer
  • Intestinal cancer
  • Colorectal cancer
  • Breast cancer
  • Liver cancer
  • Brain cancer
  • Thyroid cancer
  • Throat/nasal cancer
  • Pancreatic cancer
  • Prostate cancer
  • Ovarian cancer
  • Lung cancer (if you've never smoked)
  • Uterine cancer
  • Testicular cancer
  • Leukemia
  • Non-Hodgkins lymphoma
  • Multiple myeloma
You don’t have to do this alone. The experienced Zantac injury attorneys at Riddle & Brantley have been fighting to hold drug companies accountable for more than three decades. Our attorneys have more than 220+ years in combined legal experience and we would love to help you if we can. We believe Justice Counts and are committed to holding the manufacturer responsible if NDMA-contaminated Zantac caused cancer.  
***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924).